Researchers at Wroclaw Medical University have published a review in the International Journal of Molecular Sciences highlighting how artificial intelligence can transform nephrology by enabling early kidney disease detection and predicting disease progression before symptoms appear. Kidney diseases often develop silently, allowing the body to compensate for years until nonspecific signs like fatigue or swelling emerge. Modern medicine now focuses on modeling these diseases as dynamic processes to forecast outcomes and intervene earlier. The study, led by PhD candidate Jakub Stojanowski and Professors Tomasz Gołębiowski and Kinga Musiał, outlines various AI approaches suited for different data types. For structured tabular data such as clinical parameters, age, and lab results, traditional machine learning models like logistic regression, random forests, and XGBoost perform effectively in estimating event risks. Intermediate solutions, such as multilayer perceptrons, offer a balance by combining classical statistical advantages with the flexibility of neural networks. When handling complex data like medical images, deep neural networks are utilized. These advanced models can identify structures and patterns in histopathological diagnostics regardless of their spatial arrangement, a capability crucial for accurate image analysis. Despite the availability of sophisticated tools, the researchers emphasize practical utility over complexity. Professor Gołębiowski notes that the primary goal is whether a model can answer specific clinical questions and inform treatment decisions. Overly complex algorithms can sometimes hinder interpretation and implementation, suggesting that simpler, more transparent models may be preferable in certain scenarios. A breakthrough direction identified in the review is the integration of AI with advanced biological analyses, such as proteomics and metabolomics. This combination allows for the detection of minute disease markers long before they manifest in standard tests or visible symptoms. Professor Musiał explains that these methods possess the potential to analyze vast datasets to find patterns invisible to classical diagnostics, offering the possibility of detecting disease earlier and predicting its course before irreversible kidney damage occurs. For patients, the adoption of AI represents a significant qualitative shift toward personalized and proactive care. It enables earlier diagnosis, more accurate prognoses, and tailored treatment plans. However, the authors stress that AI remains a supportive tool rather than a decision-maker. The final determination of patient care rests with human clinicians, with technology serving to provide them with better-informed insights. As AI continues to evolve, its role in preventing chronic kidney disease and improving long-term outcomes is expected to expand significantly.